Psychological support to the compliance of the cancer patients for the management of oral therapies.

[one_full last=”yes” spacing=”yes” center_content=”no” hide_on_mobile=”no” background_color=”” background_image=”” background_repeat=”no-repeat” background_position=”left top” border_size=”0px” border_color=”” border_style=”” padding=”” margin_top=”” margin_bottom=”” animation_type=”” animation_direction=”” animation_speed=”0.1″ class=”” id=””]

In recent years, parallel to the development of new molecular target drugs, there has been a particular focus in oncology to the development of oral formulations of anticancer therapy. This interest, which is a feedback in the preferences of the patient and has been strongly supported by the pharmaceutical industry, has led to an increasing availability of oral anticancer drugs (both traditional chemotherapy, both of targeted agents) and is investing deeply the role Medical oncologist also in the organizational aspects of the service that is offered to the patient. It is estimated that about a quarter of new anticancer drugs in the developing world will have an oral formulation and has been estimated that within a decade 80% of the anticancer therapy used will be administered orally.

And ‘therefore necessary to identify reorganization processes within the day hospital and outpatient oncology that adequately address the different needs that new oral therapies require against parenteral. E ‘therefore need a process of adaptation of the service in the interest of the patient and their quality of life, to ensure the effectiveness of the treatment administered and the management of its toxicity. In this perspective, the first consideration is the recognition of the role that some professionals (the pharmacist, the psycho-oncologist, nurse, general practitioner) acquire the proper management of oral cancer therapies. The second aspect concerns the identification and the proper education of the patient and those who deal with him (the so-called caregiver). The third consideration is the importance of clinical research results in the optimum oral cancer treatments. In this sense, this project proposes an organizational, functional and research through the integration of various professionals with the aim of ensuring the effectiveness of oral anticancer therapy, proper management of toxicity, quality of life of the patient.

Responsible

Giuseppe Banna, oncologist; Sonia La Spina, psycho-oncologist.

[/one_full]